Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
University of California, San Francisco
Elevation Oncology
Seagen Inc.
Pfizer
Rutgers, The State University of New Jersey
pharmaand GmbH
Genmab
AvenCell Therapeutics, Inc.
West Virginia University
Sanofi
MacroGenics
Advanced Accelerator Applications
Tetra Bio-Pharma
InSightec
University of Wisconsin, Madison
University of Kentucky
CureOne
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Pittsburgh
University of Florida
Virginia Commonwealth University
New York State Psychiatric Institute
University of Michigan Rogel Cancer Center
Virginia Commonwealth University
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Pfizer
Calando Pharmaceuticals
Auron Healthcare GmbH
Emory University
The University of Texas Health Science Center at San Antonio
University of Wisconsin, Madison